Jyong Biotech Ltd. (MENS) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
MENS currently has 71.6M outstanding shares. with minimal authorized share overhang for future dilution. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 15, 2026 |
20-F filing | 71.6M shares outstanding |
72M | 0 |
| Jun 06, 2025 |
POS AM filing: This POS AM filing describes an offering of ordinary shares with an assumed price range of $7.50 to $8.50. The company plans to list its shares on the Nasdaq Global Market under the symbol 'MENS'. |
73M | 0 |
| Apr 23, 2025 |
POS AM filing: This POS AM filing is for an offering of ordinary shares with an assumed price range of $7.50 to $8.50. The company plans to list its shares on the Nasdaq Global Market under the symbol "MENS." |
73M | 0 |
| Mar 07, 2024 |
F-1 filing: This F-1 filing relates to an initial public offering of ordinary shares and the issuance of warrants to the underwriter's representative, Joseph Stone Capital, LLC. |
N/A | 0 |